These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 9205053

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Tightly-regulated suicide gene expression kills PSA-expressing prostate tumor cells.
    Peng W, Chen J, Huang YH, Sawicki JA.
    Gene Ther; 2005 Nov; 12(21):1573-80. PubMed ID: 16034457
    [Abstract] [Full Text] [Related]

  • 23. Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis.
    Downing S, Bumak C, Nixdorf S, Ow K, Russell P, Jackson P.
    Mol Carcinog; 2003 Nov; 38(3):130-40. PubMed ID: 14587098
    [Abstract] [Full Text] [Related]

  • 24. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC.
    Prostate; 2006 Jul 01; 66(10):1070-5. PubMed ID: 16637076
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor.
    Eder IE, Hoffmann J, Rogatsch H, Schäfer G, Zopf D, Bartsch G, Klocker H.
    Cancer Gene Ther; 2002 Feb 01; 9(2):117-25. PubMed ID: 11857028
    [Abstract] [Full Text] [Related]

  • 26. Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacy.
    Li X, Liu YH, Lee SJ, Gardner TA, Jeng MH, Kao C.
    Clin Cancer Res; 2008 Jan 01; 14(1):291-9. PubMed ID: 18172281
    [Abstract] [Full Text] [Related]

  • 27. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL, Gardner TA, Miao L, Balian G, Chung LW.
    Cancer Gene Ther; 2004 Feb 01; 11(2):148-55. PubMed ID: 14695756
    [Abstract] [Full Text] [Related]

  • 28. An oncolytic conditionally replicating adenovirus for hormone-dependent and hormone-independent prostate cancer.
    Cheng WS, Dzojic H, Nilsson B, Tötterman TH, Essand M.
    Cancer Gene Ther; 2006 Jan 01; 13(1):13-20. PubMed ID: 16052227
    [Abstract] [Full Text] [Related]

  • 29. Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer.
    Xie X, Zhao X, Liu Y, Zhang J, Matusik RJ, Slawin KM, Spencer DM.
    Cancer Res; 2001 Sep 15; 61(18):6795-804. PubMed ID: 11559553
    [Abstract] [Full Text] [Related]

  • 30. A novel targeting modality to enhance adenoviral replication by vitamin D(3) in androgen-independent human prostate cancer cells and tumors.
    Hsieh CL, Yang L, Miao L, Yeung F, Kao C, Yang H, Zhau HE, Chung LW.
    Cancer Res; 2002 Jun 01; 62(11):3084-92. PubMed ID: 12036918
    [Abstract] [Full Text] [Related]

  • 31. Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models.
    Denmeade SR, Sokoll LJ, Chan DW, Khan SR, Isaacs JT.
    Prostate; 2001 Jun 15; 48(1):1-6. PubMed ID: 11391681
    [Abstract] [Full Text] [Related]

  • 32. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X, Jung C, Liu YH, Bae KH, Zhang YP, Zhang HJ, Vanderputten D, Jeng MH, Gardner TA, Kao C.
    J Gene Med; 2006 Jun 15; 8(6):679-89. PubMed ID: 16570242
    [Abstract] [Full Text] [Related]

  • 33. Construction and in vivo evaluation of an anti-PSA x anti-CD3 bispecific antibody for the immunotherapy of prostate cancer.
    Katzenwadel A, Schleer H, Gierschner D, Wetterauer U, Elsässer-Beile U.
    Anticancer Res; 2000 Jun 15; 20(3A):1551-5. PubMed ID: 10928069
    [Abstract] [Full Text] [Related]

  • 34. The atypical GATA protein TRPS1 represses androgen-induced prostate-specific antigen expression in LNCaP prostate cancer cells.
    van den Bemd GJ, Jhamai M, Brinkmann AO, Chang GT.
    Biochem Biophys Res Commun; 2003 Dec 19; 312(3):578-84. PubMed ID: 14680804
    [Abstract] [Full Text] [Related]

  • 35. Gene therapy for prostate cancer by targeting poly(ADP-ribose) polymerase.
    Trofimova I, Dimtchev A, Jung M, Rosenthal D, Smulson M, Dritschilo A, Soldatenkov V.
    Cancer Res; 2002 Dec 01; 62(23):6879-83. PubMed ID: 12460902
    [Abstract] [Full Text] [Related]

  • 36. Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer.
    Li X, Zhang YP, Kim HS, Bae KH, Stantz KM, Lee SJ, Jung C, Jiménez JA, Gardner TA, Jeng MH, Kao C.
    Cancer Res; 2005 Mar 01; 65(5):1941-51. PubMed ID: 15753394
    [Abstract] [Full Text] [Related]

  • 37. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models.
    Miyake H, Nelson C, Rennie PS, Gleave ME.
    Cancer Res; 2000 May 01; 60(9):2547-54. PubMed ID: 10811138
    [Abstract] [Full Text] [Related]

  • 38. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
    Petrigliano FA, Virk MS, Liu N, Sugiyama O, Yu D, Lieberman JR.
    Prostate; 2009 Sep 15; 69(13):1422-34. PubMed ID: 19489029
    [Abstract] [Full Text] [Related]

  • 39. Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.
    Rekasi Z, Schally AV, Plonowski A, Czompoly T, Csernus B, Varga JL.
    Prostate; 2001 Aug 01; 48(3):188-99. PubMed ID: 11494334
    [Abstract] [Full Text] [Related]

  • 40. Transcription-targeted gene therapy for androgen-independent prostate cancer.
    Martiniello-Wilks R, Tsatralis T, Russell P, Brookes DE, Zandvliet D, Lockett LJ, Both GW, Molloy PL, Russell PJ.
    Cancer Gene Ther; 2002 May 01; 9(5):443-52. PubMed ID: 11961667
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.